Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1968 1
1989 1
1997 1
1998 2
1999 1
2000 1
2006 2
2007 1
2010 1
2014 1
2019 3
2020 9
2021 6
2022 5
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

32 results

Results by year

Filters applied: . Clear all
Page 1
Controlled Trial of Budesonide-Formoterol as Needed for Mild Asthma.
Beasley R, Holliday M, Reddel HK, Braithwaite I, Ebmeier S, Hancox RJ, Harrison T, Houghton C, Oldfield K, Papi A, Pavord ID, Williams M, Weatherall M; Novel START Study Team. Beasley R, et al. Among authors: oldfield k. N Engl J Med. 2019 May 23;380(21):2020-2030. doi: 10.1056/NEJMoa1901963. Epub 2019 May 19. N Engl J Med. 2019. PMID: 31112386 Clinical Trial.
Medicinal applications of cannabis/cannabinoids.
Braithwaite I, Bhagavan C, Doppen M, Kung S, Oldfield K, Newton-Howes G. Braithwaite I, et al. Among authors: oldfield k. Curr Opin Psychol. 2021 Apr;38:1-10. doi: 10.1016/j.copsyc.2020.06.002. Epub 2020 Jun 20. Curr Opin Psychol. 2021. PMID: 32652488 Review.
Budesonide-formoterol reliever therapy versus maintenance budesonide plus terbutaline reliever therapy in adults with mild to moderate asthma (PRACTICAL): a 52-week, open-label, multicentre, superiority, randomised controlled trial.
Hardy J, Baggott C, Fingleton J, Reddel HK, Hancox RJ, Harwood M, Corin A, Sparks J, Hall D, Sabbagh D, Mane S, Vohlidkova A, Martindale J, Williams M, Shirtcliffe P, Holliday M, Weatherall M, Beasley R; PRACTICAL study team. Hardy J, et al. Lancet. 2019 Sep 14;394(10202):919-928. doi: 10.1016/S0140-6736(19)31948-8. Epub 2019 Aug 23. Lancet. 2019. PMID: 31451207 Clinical Trial.
Budesonide-formoterol reliever therapy in intermittent versus mild persistent asthma.
Papi A, Braithwaite I, Ebmeier S, Hancox RJ, Harrison T, Holliday M, Houghton C, Morandi L, Oldfield K, Pavord ID, Reddel HK, Williams M, Weatherall M, Beasley R; NovelSTART Study Team. Papi A, et al. Among authors: oldfield k. Eur Respir J. 2021 Feb 17;57(2):2003064. doi: 10.1183/13993003.03064-2020. Print 2021 Feb. Eur Respir J. 2021. PMID: 33060151 Free article. No abstract available.
Effects of inhaled JAK inhibitor GDC-4379 on exhaled nitric oxide and peripheral biomarkers of inflammation.
Chen H, Kunder R, Zou Y, Staton T, Zhu R, Galanter J, Gugelmann H, Owen R, Grimbaldeston MA, Chang JK, Durk MR, Eliahu A, Wilson MS, Choy DF, Wilson M, Black M, Doppen M, Kung S, Oldfield K, Sparks J, Beasley R, Braithwaite I. Chen H, et al. Among authors: oldfield k. Pulm Pharmacol Ther. 2022 Aug;75:102133. doi: 10.1016/j.pupt.2022.102133. Epub 2022 May 26. Pulm Pharmacol Ther. 2022. PMID: 35644305 Clinical Trial.
Asthma control with ICS-formoterol reliever versus maintenance ICS and SABA reliever therapy: a post hoc analysis of two randomised controlled trials.
Hatter L, Houghton C, Bruce P, Holliday M, Eathorne A, Pavord I, Reddel HK, Hancox RJ, Braithwaite I, Oldfield K, Papi A, Weatherall M, Beasley R; Novel START and PRACTICAL study teams. Hatter L, et al. Among authors: oldfield k. BMJ Open Respir Res. 2022 Aug;9(1):e001271. doi: 10.1136/bmjresp-2022-001271. BMJ Open Respir Res. 2022. PMID: 36007980 Free PMC article.
32 results